FDA — authorised 12 March 1958
- Application: NDA011338
- Marketing authorisation holder: WYETH AYERST
- Local brand name: FLUOTHANE
- Indication: LIQUID — INHALATION
- Status: approved
🇺🇸 Anestan in United States
FDA authorised Anestan on 12 March 1958
Marketing authorisations
FDA — authorised 9 May 1972
- Application: ANDA080810
- Marketing authorisation holder: HALOCARBON
- Local brand name: HALOTHANE
- Indication: LIQUID — INHALATION
- Status: approved
FDA
- Status: approved
Anestan in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Anestan approved in United States?
Yes. FDA authorised it on 12 March 1958; FDA authorised it on 9 May 1972; FDA has authorised it.
Who is the marketing authorisation holder for Anestan in United States?
WYETH AYERST holds the US marketing authorisation.